´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ)The Liver Week 2021 Virtual Confernence Day 1 : 2021-05-13±³À°ÀÏÀÚ : 2021-05-13
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ)The Liver Week 2021 Virtual Confernence Day 1 ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ Áغñ»ç¹«±¹
¿¬¶ôó : 02-373-1005
À̸ÞÀÏ :
kaslsecretariat@hbni.co.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 18 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 110,000¿ø
ºñ°í Member-70,000/ Resident, Trainee, Fellow, Researcher, Army Doctor, Nurse, or Others-40,000 Non-Member, Healthcare Professional-110,000 International Delegate-USD 75 Foreign Investigator Award Winner-USD 40
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 09:00~09:20 Hepatitis B Virus Treatment New Indications, New Endpoints: When to Start, Change and Stop? Hyung Joon Yim(Korea Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 09:20~09:40 Hepatitis C Virus Simplified Algorithm for Treatment: Who Is Eligible for Simplified Treatment? In Hee Kim(Jeonbuk National Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 09:40~10:00 Individualized Treatment of Viral Hepatitis B and C Based on Comorbidities Young-Joo Jin(Inha Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 10:00~10:20 The Recent Updates in HAV, HDV, and HEV Sae Hwan Lee(Soonchunhyang Univ.)
Åä·Ð 05-13 ¿Â¶óÀÎ °³ÃÖ 10:20~10:30 Discussion ()
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 10:40~11:00 The Epidemiology and Virology of COVID-19 Infection Won-Suk Choi(Korea Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 11:00~11:20 Recent Practice Guidelines for Patients with Liver Disease in the Era of COVID-19 Jeong-Hoon Lee(Seoul National Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 11:20~11:40 The Relationship between COVID-19 and Liver Disease Woo Jin Jung(Keimyung Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 11:40~12:00 The Challenges and Achievements in COVID-19 Treatment and Vaccines Pyoeng Gyun Choe(Seoul National Univ.)
Åä·Ð 05-13 ¿Â¶óÀÎ °³ÃÖ 12:00~12:10 Discussion ()
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 13:10~13:30 How to Identify High-Risk Individuals in Alcoholic Liver Disease Do Seon Song(The Catholic Univ. of Korea)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 13:30~13:50 How to Predict Rapid Progression of Fibrosis in Nonalcoholic Fatty Liver Disease Byoung Kuk Jang(Keimyung Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 13:50~14:10 Metabolism-Based Medical and Surgical Interventions for Nonalcoholic Fatty Liver Disease Eun-Jung Rhee(Sungkyunkwan Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 14:10~14:30 Liver Transplantation and beyond for Alcohol-Related Liver Failure Ho Joong Choi(The Catholic Univ. of Korea)
Åä·Ð 05-13 ¿Â¶óÀÎ °³ÃÖ 14:30~14:40 Discussion ()
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 14:50~15:10 Recent Advances in Noninvasive Diagnostic Approaches to Portal Hypertension Seong Hee Kang(Yonsei Univ. Wonju)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 15:10~15:30 Challenges in Cirrhosis Management Focused on Acute Kidney Injury and Refractory Ascites Yeon Seok Seo(Korea Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 15:30~15:50 Pharmacological Treatment of Portal Hypertension: A 2021 Update and Revisit Jae Young Jang(Soonchunhyang Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 15:50~16:10 Non-Pharmacological Treatment of Portal Hypertension: A 2021 Update and Revisit Hyo Cheol Kim(Seoul National Univ.)
Åä·Ð 05-13 ¿Â¶óÀÎ °³ÃÖ 16:10~16:20 Discussion ()
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 09:00~09:20 Human Immunity and Single-Cell Multi-Omics Approaches Jong-Eun Park(Korea Advanced Institute of Science and Technology)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 09:20~09:40 Transplantation of Bioengineered Livers into Immunosuppressed Pigs Dong Jin Joo(Yonsei Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 09:40~10:00 Three Dimensional Human Liver-Chip Yoon-Kyoung Cho(Ulsan National Institute of Science and Technology)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 10:00~10:20 Fecal Microbiota Transplantation (FMT) Application to Liver Disease Sowon Park(Yonsei Univ.)
Åä·Ð 05-13 ¿Â¶óÀÎ °³ÃÖ 10:20~10:30 Discussion ()
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 10:40~11:00 Reprograming Hepatocytes in Severe Alcoholic Hepatitis Jeongeun Hyun(Dankook Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 11:00~11:20 Sphingomyelin and Hepatocyte Pyroptosis in Nonalcoholic Steatohepatitis Eun Hee Koh(Univ. of Ulsan)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 11:20~11:40 Role of Intestine-Derived HDL on LPS Action in Gut-Liver Axis Yong-Hyun Han(Kangwon National Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 11:40~12:00 Neutrophils in Alcohol-Associated Liver Disease Bin Gao(National Institute on Alcohol Abuse and Alcoholism USA)
Åä·Ð 05-13 ¿Â¶óÀÎ °³ÃÖ 12:00~12:10 Discussion ()
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 13:10~13:30 In Vivo and In Vitro Models for Alcoholic and Nonalcoholic Liver Disease Hyo-Jung Kwon(Chungnam National Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 13:30~13:50 The Generation of Expandable Liver Organoids Myung Jin Son(Korea Research Institute of Bioscience and Biotechnology)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 13:50~14:10 Hepatic Immune Cell Isolation and Analysis in Mice and Humans Young-Sun Lee(Korea Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 14:10~14:30 Exosome Isolation Technique and Its Application to Liver Disease Wonhyo Seo(Ewha Womans Univ.)
Åä·Ð 05-13 ¿Â¶óÀÎ °³ÃÖ 14:30~14:40 Discussion ()
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 14:50~15:10 Glutamine and Immune Checkpoint in Cancer Cells Keun-Gyu Park(Kyungpook National Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 15:10~15:30 Hippo Signaling in HCC Development Wantae Kim(Chungnam National Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 15:30~15:50 Mesenchymal Stem Cell-Derived Factors Regulate Liver Fibrosis Youngmi Jung(Pusan National Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 15:50~16:10 A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis Tae Gyu Oh(Salk Institute for Biological Studies USA)
Åä·Ð 05-13 ¿Â¶óÀÎ °³ÃÖ 16:10~16:20 Discussion ()
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 09:00~09:20 Questionnaire Analysis on Education and Management for Abdominal Ultrasonography Training Specialists Seung Kak Shi(Gachon Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 09:20~09:40 Role and Ethics of Abdominal Ultrasonography Training Specialists Young Seok Cho(Tha Catholic Univ. of Korea)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 09:40~10:00 Artificial Intelligence-Based Medical Image Analysis Hwiyoung Kim(Yonsei Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 10:00~10:20 How To Write a Report of Abdominal Ultrasonography: Focusing on Cases Han Ah Lee(Inje Univ.)
Åä·Ð 05-13 ¿Â¶óÀÎ °³ÃÖ 10:20~10:30 Discussion ()
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 10:40~11:00 Settings and Practice of Contrast-Enhanced Ultrasonography Soo Young Park(Kyungpook National Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 11:00~11:20 Ultrasonography Cases of Various Atypical Hepatic Tumors Ki Tae Suk(Hallym Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 11:20~11:40 Non-Invasive Methods for Diagnosis of NAFLD (Ultrasonography, Fibroscan, Shear Wave, Etc.) Hye Won Lee(Yonsei Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 11:40~12:00 Various Cases of Liver Disease Applying Doppler Ultrasonography Jeong Eun Song(Daegu Catholic Univ.)
Åä·Ð 05-13 ¿Â¶óÀÎ °³ÃÖ 12:00~12:10 Discussion ()
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 13:10~13:30 Unmet Need for National Reimbursement Policy for Hepatocellular Carcinoma Eun Sun Jang(Seoul National Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 13:30~13:50 Expanding Reimbursement Policy on Non-Reimbursable Services in Hepatology Soon Sun Kim(Ajou Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 13:50~14:10 Role and Mission of Patient Classification System TFT in KASL Hyun Woong Lee(Yonsei Univ.)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 14:10~14:30 TBD Joong Kyu Lee(Ministry of Health and Welfare)
Åä·Ð 05-13 ¿Â¶óÀÎ °³ÃÖ 14:30~14:40 Discussion ()
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 14:50~15:10 The Political and Clinical Progress for Hepatitis C Virus Elimination in Taiwan: From Beginnings to Present Jia-Horng Kao(National Taiwan Univ. Taiwan)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 15:10~15:30 The Political and Clinical Progress for Hepatitis C Virus Elimination in Egypt: From Beginnings to Present Imam Waked(National Liver Institute Egypt)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 15:30~15:50 The Political and Clinical Progress for Hepatitis C Virus Elimination in Australia: From Beginnings to Present Gregory Dore(Kirby Institute Australia)
±³À°½Ã°£ 05-13 ¿Â¶óÀÎ °³ÃÖ 15:50~16:10 The Critical Appraisal for Policy Progress to Date: What Is Needed and How Should It Proceed? Young-Suk Lim(Univ. of Ulsan Korea)
Åä·Ð 05-13 ¿Â¶óÀÎ °³ÃÖ 16:10~16:30 Discussion ()